TITLE

Cystic Fibrosis: Using genetic association to identify modifiers of disease variability in cystic fibrosis

AUTHOR(S)
Cutting, Garry R.
PUB. DATE
August 2006
SOURCE
European Journal of Human Genetics;Aug2006, Vol. 14 Issue 8, p890
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article investigates the use of genetic association to identify modifiers of disease variability in cystic fibrosis by researchers from Baltimore, Maryland. Scientists have been puzzled why patients with the same disease can have different outcomes. It has been thought that the identification of the underlying causes of disease variation can be of considerable prognostic value. In this study, the severity of life-limiting pulmonary disease in cystic fibrosis patients is examined in relation to transforming growth factor beta-1 gene.
ACCESSION #
21678505

 

Related Articles

  • Arkadia enhances nodal-related signalling to induce mesendoderm. Niederlander, Christiane; Walsh, James J.; Episkopou, Vasso; Jones, C. Michael // Nature;4/12/2001, Vol. 410 Issue 6830, p830 

    Presents a study to investigate the function of Arkadia and its role in establishing Spemann's organizer. How the nuclear protein Arkadia specifically potentiates the mesendoderm-inducing activity of a subset of transforming growth factor (TGF)-beta family members; Identification of Arkadia as...

  • Lack of Skin Fibrosis in Tight Skin (TSK) Mice with Targeted Mutation in the Interleukin-4Rα and Transforming Growth Factor-β Genes. McGaha, Tracy; Saito, Shinichiro; Phelps, Robert G.; Gordon, Ronald; Noben-Trauth, Nancy; Paul, William E.; Bona, Constantin // Journal of Investigative Dermatology;Jan2001, Vol. 116 Issue 1, p136 

    SummaryScleroderma is a disorder characterized by fibrosis of the skin and internal organs and autoimmunity. Whereas the cause is unknown, interleukin-4 and transforming growth factor-β have been postulated to play a major part in the fibrosis. To investigate the part played by these...

  • Transforming Growth Factor-Beta and the Kidney: What We Know and What We Can Do? Hai-Chun Yang; Yiqin Zuo; Fogo, Agnes B. // Current Enzyme Inhibition;Jul2010, Vol. 6 Issue 2, p87 

    Transforming growth factor-� (TGF-�) and its receptors are expressed in the kidney. The effects of TGF-� are mainly through activation of Smad pathways. In different pathophysiological situations such as development, immunomodulation, fibrosis and cell response, TGF-�...

  • LUNG ALERT...........: Which smokers will acquire COPD? Johnson, M. // Thorax;Nov2004, Vol. 59 Issue 11, p965 

    This article presents information about a study which analyzes transforming growth factor-β1 (TGFβ1) gene in chronic obstructive pulmonary disease (COPD). There was significant evidence of linkage in smokers between chromosome 19q and the pre-bronchodilator FEV1. This linkage peak was...

  • Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in Japanese. Okamoto, Yoshihiro; Gotoh, Yoshimitsu; Uemura, Osamu; Tanaka, Soichi; Ando, Tsunesaburo; Nishida, Mikio // Disease Markers;2005, Vol. 21 Issue 2, p71 

    Transforming growth factor-beta1 (TGF-β1), a multi-functional cytokine, is involved in regulating a variety of cellular activities and the serum/plasma TGF-β1 level is altered with various diseases. However, most published reports have described adult patients, and so we investigated the...

  • Cell polarity: Undoing tight junctions. Bussell, Katrin // Nature Reviews Molecular Cell Biology;May2005, Vol. 6 Issue 5, p358 

    Discusses research being done on the promotion of epithelial-mesenchymal transition by transforming growth factor-Î’. Reference to a study by Jeff Wrana et al, published in the 2005 issue of "Science"; Mechanism of action of transforming growth factor-Î’.

  • Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-β signaling. Youping Sun; Lowther, William; Kato, Katsuaki; Bianco, Caterina; Kenney, Nicholas; Strizzi, Luigi; Raafat, Dina; Hirota, Morihisa; Khan, Nadia I.; Bargo, Sharon; Jones, Brenda; Salomon, David; Callahan, Robert // Oncogene;8/11/2005, Vol. 24 Issue 34, p5365 

    We present evidence that Notch4ICD attenuates TGF-β signaling. Cells expressing the activated form of the Notch4 receptor (ICD4) were resistant to the growth-inhibitory effects of TGF-β. Notch4ICD was found to bind to Smad2, Smad3 and Smad4 but with higher affinity to Smad3. Deletion...

  • Role of Transforming Growth Factor-Beta Signaling Modulators in Periodontal Disease. Bains-Dahia, S.; Gauldie, J.; Häkkinen, L.; Larjava, H // UBC Medical Journal;Apr2011, Vol. 2 Issue 2, p25 

    Transforming growth factor beta 1 (TGF-β1) plays a crucial role in protection of many organs from inflammation. TGF-β1 is expressed as a latent cytokine and needs to be activated for function. Epithelial integrin avβ6 and thrombospondin-1 (TSP-1) serve as activators of TGF-β1. Mice...

  • Transforming Growth Factor-β1-Mediated Neuroprotection Against Excitotoxic Injury in Vivo. Delphine Boche // Journal of Cerebral Blood Flow & Metabolism;Oct2003, Vol. 23 Issue 10, p1174 

    SUMMARY: Ischemic preconditioning is a phenomenon that describes how a sublethal ischemic insult can induce tolerance to subsequent ischemia. This phenomenon has been observed after focal or global ischemia in different animal models. However, the hypothesis that bacterial infection might lead...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics